Phase 4 Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 70 years old.
- You have been diagnosed with active Crohn's disease, confirmed by a specific type of camera examination of the gut (endoscopy) and blood or stool tests, or imaging scans.
- Your Crohn's disease symptoms score above a certain level on a standard measurement scale used by doctors (confirm with trial site for exact score details).
- You previously tried a type of medication called a TNF inhibitor, but it did not work well enough or stopped working over time.
- You have been taking a medication called ustekinumab at the standard dose for at least 16 to 24 weeks, but your Crohn's disease is still active.
- You are willing and able to sign a consent form and follow the study's requirements throughout the trial.
- A doctor has reviewed your overall health — including blood tests, a physical exam, a chest X-ray, and a heart tracing (ECG) — and considers you generally healthy enough to participate.
Who may not be able to join:
- You have a known allergy to upadacitinib (UPA) or ustekinumab (UST), or to any of their ingredients.
- You have untreated or unresolved pre-cancerous changes (high-grade dysplasia) or cancer of the colon.
- You have an active infection right now, such as pneumonia, a kidney infection, or shingles, or you have a long-term (chronic) infection that the doctor feels makes participation unsafe.
- You currently need surgery for your Crohn's disease, or it is expected that you will need surgery during the study.
- You have been found to have blood clots, based on an ultrasound scan of your legs or a blood test (D-dimer).
- You have a history of lymphoma or other diseases affecting the lymph system, or you currently have swollen lymph nodes or an enlarged spleen that may suggest such a condition.
- You have a condition that weakens your immune system, such as a condition you were born with, HIV infection, or you have received an organ transplant.
- You are pregnant, or a pregnancy test at the start of the study comes back positive.
- You are currently breastfeeding or planning to become pregnant during the study.
- You have used illegal drugs or misused alcohol within the past year before joining the study.
- The doctor running the trial decides, for any reason, that the study is not suitable for you.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86-020-38254101
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The primary endpoint of the study is the endoscopic remission rate at week 16.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.